CEO Michael Neidorff takes medical leave; James Dallas named Acting Chairman

CENTENE CORP

Michael Neidorff granted paid medical leave of absence as CEO, Chairman, and director effective Feb 23, 2022.
James Dallas appointed Acting Chairman; Office of Chairman (London, Layton, Asher, Bagley) to manage daily operations.
Board's CEO succession process ongoing, targeted for completion in Q2 2022.
Neidorff led Centene for 26 years, growing it to Fortune 24 with over $125B revenue.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

James Dallas

Acting Chairman

CNC · CENTENE CORP

Effective: 2022-02-23
Filed: February 24, 2022, 6:59 PM ET

The Board also (i) appointed James Dallas as the Acting Chairman of the Board

Role change

Michael Neidorff

Chief Executive Officer, Chairman, and Director

CNC · CENTENE CORP

Effective: 2022-02-23
Filed: February 24, 2022, 6:59 PM ET

On February 23, 2022, the Board of Directors (the “Board”) of Centene Corporation (the “Company”) approved a request from Michael Neidorff for a paid medical leave of absence from his roles as Chief Executive Officer, Chairman, and a director of the Company (the “Leave of Absence”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Dallas was appointed as Acting Chairman at CENTENE CORP.

Action: appointed as Acting Chairman
Role: Acting Chairman

Exact text from the filing

The Board also (i) appointed James Dallas as the Acting Chairman of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Neidorff changed role as Chief Executive Officer, Chairman, and Director at CENTENE CORP.

Action: granted medical leave of absence
Role: Chief Executive Officer, Chairman, and Director

Exact text from the filing

On February 23, 2022, the Board of Directors (the “Board”) of Centene Corporation (the “Company”) approved a request from Michael Neidorff for a paid medical leave of absence from his roles as Chief Executive Officer, Chairman, and a director of the Company (the “Leave of Absence”).

View on SEC.gov

CENTENE CORP filing history →

Source: SEC EDGAR

accession 0001071739-22-000077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.